China Medical & HealthCare : SECOND SUPPLEMENTAL AGREEMENT IN RELATION TO THE LOAN AGREEMENT (in PDF)

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

China Medical & HealthCare Group Limited

(Incorporated in Bermuda with limited liability)

(Stock Code: 383) SECOND SUPPLEMENTAL AGREEMENT IN RELATION TO THE LOAN AGREEMENT

The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower (a non wholly-owned subsidiary of the Company) entered into the Second Supplemental Agreement pursuant to which the parties agreed to (i) extend the Repayment Date under the Loan Agreement as amended by the Supplemental Agreement from 23 June 2017 to 23 July 2018 and (ii) amend the interest rate for the first interest period commencing on 23 June 2017 to the date falling one (1) month thereafter to 25.805% per annum and to 12% per annum for the reminder of the term.

This announcement is made by the board of Directors pursuant to Rule 13.09 and Rule 14.36 of the Listing Rules.

Unless otherwise stated, definitions used in the Company's announcements dated 23 December 2015 and 12 January 2017 respectively shall have the same meanings when used in this announcement.

The Board announces that on 26 June 2017 (after trading hours), the Lender and the Borrower (a non wholly-owned subsidiary of the Company) entered into the second supplemental loan agreement (the "Second Supplemental Agreement") pursuant to which the parties agreed to

(i) extend the Repayment Date under the Loan Agreement as amended by the Supplemental Agreement from 23 June 2017 to 23 July 2018 and (ii) amend the interest rate for the first interest period commencing on 23 June 2017 to the date falling one (1) month thereafter to 25.805% per annum and to 12% per annum for the reminder of the term. The Loan has been used and applied by the Borrower as its general working capital. The terms of the Second Supplemental Agreement were arrived between the parties after arm's length negotiation.

The Directors consider that the terms of the Second Supplemental Agreement are fair, reasonable and beneficial to the Company and are in the interests of the shareholders as a whole.

Save as disclosed herein, all other terms and conditions of the Loan Agreement as amended by the Supplemental Agreement remain unchanged.

By Order of the Board

China Medical & HealthCare Group Limited Dr. Lim Cheok Peng

Chairman

Hong Kong, 26 June 2017

As at the date of this announcement, the Board comprises: - Executive Directors

Ms. Chong Sok Un (Deputy Chairman), Dr. Jonathan Weiyan Seah (Chief Executive Officer), Dato' Wong Peng Chong and Mr. Kong Muk Yin

Non-Executive Directors

Dr. Lim Cheok Peng (Chairman) and Mr. Liao Feng

Independent Non-Executive Directors

Mr. Lau Siu Ki, Mr. Zhang Jian and Dr. Xia Xiaoning